RAC 0.63% $1.59 race oncology ltd

General Comments / Chat, page-11427

  1. 5,786 Posts.
    lightbulb Created with Sketch. 1332
    Yes that's fine that AML will be running behind the CPACS trial I'm sure that's the plan for good reason.
    But its been a year or there abouts that RAC announced we had a lead investigator that wanted to use bisantrene and many months since we raised the money, why are we not told who they are.(What's the reason) ?
    We don't need the details of when and where it will be held if they are still working on that ,
    but the name of who they are I would of though should of be shared by now at the minimum since we funded this.
    And John it does matter as AML is still worth something and good to have more cement AML trials just in case back up.
    Last edited by Hunterr: 09/09/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.